Global healthcare PE deal value soared to $115bn, finds Bain & Company
The surge was propelled by an increase in large deals and greater interest in biopharma and healthcare IT, Nirad Jain said in an exclusive interview with PE Hub.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
